Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DIA MEDICO ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   5.3% 8.3% 5.1% 4.5% 18.8% 12.3% 20.6% 20.4%   Credit score (0-100)   45 32 45 48 7 18 4 4   Credit rating   BBB BB BBB BBB B BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   642 650 719 751 106 63.7 0.0 0.0   EBITDA   63.0 210 221 147 -198 64.6 0.0 0.0   EBIT   63.0 210 221 147 -198 64.6 0.0 0.0   Pre-tax profit (PTP)   61.0 165.0 219.0 145.0 -200.0 64.3 0.0 0.0   Net earnings   47.0 118.0 171.0 106.7 -200.8 61.7 0.0 0.0   Pre-tax profit without non-rec. items   61.0 165 219 145 -200 64.3 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   271 288 357 357 48.1 110 -15.2 -15.2   Interest-bearing liabilities   18.0 0.0 13.0 17.5 0.0 0.0 15.2 15.2   Balance sheet total (assets)   387 393 533 506 85.1 131 0.0 0.0   Net Debt   -214 -345 -377 -355 -46.7 -30.6 15.2 15.2     See the entire balance sheet 1000.0 Volume  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   642 650 719 751 106 63.7 0.0 0.0   Gross profit growth   0.0% 1.2% 10.6% 4.4% -85.9% -40.0% -100.0% 0.0%   Employees   0 1,000 1 1 1 0 0 0   Employee growth %   0.0% 0.0% -99.9% 0.0% 0.0% -100.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   387 393 533 506 85 131 0 0   Balance sheet change%   0.0% 1.6% 35.6% -5.1% -83.2% 54.2% -100.0% 0.0%   Added value   63.0 210.0 221.0 147.0 -197.6 64.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 -0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.8% 32.3% 30.7% 19.6% -186.1% 101.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.3% 64.1% 47.5% 28.1% -66.9% 59.7% 0.0% 0.0%   ROI %   21.8% 58.9% 66.9% 39.3% -93.5% 81.9% 0.0% 0.0%   ROE %   17.3% 42.2% 53.0% 29.9% -99.2% 78.2% 0.0% 0.0%   1000.0 Solidity  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Equity ratio %   70.0% 73.3% 67.0% 70.5% 56.5% 83.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -339.7% -164.3% -170.6% -241.3% 23.6% -47.3% 0.0% 0.0%   Gearing %   6.6% 0.0% 3.6% 4.9% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   22.2% 55.6% 15.4% 7.5% 28.1% 0.0% 0.0% 0.0%   1000.0 Liquidity  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Quick Ratio   3.2 6.2 4.1 4.0 2.3 6.1 0.0 0.0   Current Ratio   3.2 6.2 4.1 4.0 2.3 6.1 0.0 0.0   Cash and cash equivalent   232.0 345.0 390.0 372.3 46.7 30.6 0.0 0.0   1000.0 Capital use efficiency  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   240.0 330.0 402.0 380.8 48.1 109.8 -7.6 -7.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 221 147 -198 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 221 147 -198 0 0 0   EBIT / employee   0 0 221 147 -198 0 0 0   Net earnings / employee   0 0 171 107 -201 0 0 0